Sander Alexander Antonius Kooijmans

Title: Sander Alexander Antonius Kooijmans and Lipid Nanoparticle Innovation.

Introduction

Sander Alexander Antonius Kooijmans is an inventor associated with Yalelaan, the Netherlands. His patent work focuses on lipid nanoparticles designed to deliver nucleic acids, including messenger RNA (mRNA).

Latest Patents

Kooijmans is named on 1 patent: “Lipid nanoparticles comprising sterols and mRNA.” The invention concerns lipid nanoparticles containing an ionizable lipid, a phospholipid, a sterol, a PEG lipid, and one or more nucleic acids. A defining feature is that the particles contain less than about 1 mol% of a C14-PEG2000 lipid, alongside specified proportions of other lipids.

The patent describes using these nanoparticles to deliver nucleic acids for immunogenic purposes, particularly mRNA delivery. Potential applications include vaccines for cancer and infectious diseases. It also covers methods for preparing the lipid nanoparticles.

Career Highlights

Kooijmans’s listed company affiliations include Vrije Universiteit Brussel and Etherna Immunotherapies NV. His patent reflects work in lipid nanoparticle formulations and nucleic-acid delivery.

Collaborations

His named coworkers include Stefaan De Koker and Raymond Michel Schiffelers. Their shared area of work, as reflected in the patent, involves lipid nanoparticles and mRNA delivery.

Conclusion

Sander Alexander Antonius Kooijmans’s patent contribution centers on lipid nanoparticles formulated for mRNA delivery, with potential applications in vaccines for cancer and infectious diseases.